Back to search
Desmoid-type Fibromatosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Desmoid-type Fibromatosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Desmoid-type Fibromatosis trials you may qualify forThis study is being conducted to study how nirogacestat may affect the ovarian function of adult premenopausal women with progressing desmoid tumors/aggressive…
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patient…
This phase I/II trial evaluates the highest safe dose, side effects, and possible benefits of tegavivint in treating patients with solid tumors that has come ba…
This is an open-label, multicenter, single-arm phase 2 clinical study designed to evaluate the efficacy, safety, tolerability, patient-reported outcomes (PROs),…
This is a multicenter, two-part trial in participants with FAP.
This study is being conducted to characterize the efficacy and safety of nirogacestat in Japanese adults with progressing desmoid tumors/aggressive fibromatosis…
This program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee, and applicable co…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…